The application of aptamers in cancer research: an up-to-date review

By Hu Meidi   Zhang Kunhe  

Future Oncology, Vol. 9, Iss. 3, 2013-03 ,pp. : 369-376

Future Medicine

Access to resources Recommend Favorite

Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (Review)

By                    

International Journal of Oncology, Vol. 45, Iss. 3, 2014-01 ,pp. : 909-918

Spandidos Publications

Access to resources Recommend Favorite

Isolated lung perfusion for the treatment of pulmonary metastases current mini-review of work in progress

By Van Putte B.P.   Hendriks J.M.H.   Romijn S.   Van Schil P.E.Y.  

Surgical Oncology, Vol. 12, Iss. 3, 2003-11 ,pp. : 187-193

Elsevier

Access to resources Recommend Favorite

Energy Balance, Polymorphisms in the mTOR Pathway, and Renal Cell Carcinoma Risk

By Shu Xiang   Lin Jie   Wood Christopher G.   Tannir Nizar M.   Wu Xifeng  

Journal of the National Cancer Institute, Vol. 105, Iss. 6, 2013-03 ,pp. : 424-432

Oxford University Press

Access to resources Recommend Favorite

Targeting the mTOR pathway using deforolimus in cancer therapy

By Mahalingam Devalingam   Sankhala Kamalesh   Mita Alain   Giles Francis J   Mita Monica M  

Future Oncology, Vol. 5, Iss. 3, 2009-04 ,pp. : 291-303

Future Medicine

Access to resources Recommend Favorite